Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Cash from Investing Activities Growth (5y) (2017 - 2026)

Analysis

Iqvia Holdings (IQV) Cash from Investing Activities Growth (5y) (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -15.54%
Mar 31, 2026 -2.18%
Dec 31, 2025 -36.15%
Sep 30, 2025 -23.56%
Jun 30, 2025 -9.58%
Mar 31, 2025 -15.25%
Dec 31, 2024 -2.06%
Sep 30, 2024 -8.41%
Jun 30, 2024 -2.53%
Mar 31, 2024 0.06%
Dec 31, 2023 -3.56%
Sep 30, 2023 -25.78%
Jun 30, 2023 -12.55%
Mar 31, 2023 -13.09%
Dec 31, 2022 -2.77%
Sep 30, 2022 -16.51%
Jun 30, 2022 0.10%
Mar 31, 2022 -20.63%
Dec 31, 2021 -18.70%
Sep 30, 2021 -118.47%